Journal: Biomedical journal
Article Title: Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
doi: 10.1016/j.bj.2022.07.008
Figure Lengend Snippet: Fig. 3 Lidocaine in combination with dexamethasone has an additive modulatory effect different signaling pathways. TNFR signaling (A): THP1-XBlueTM-defMyD cells were stimulated ON with hTNFa and modulated or not with lidocaine and/or dexamethasone, and hIL-8 was measured in culture supernatants. IFNgR signaling (B): B16 IFNg SEAP reporter cells were stimulated ON with mIFNg in presence or not of different concentrations of lidocaine and/or dexamethasone, and SEAP activity was measured in supernatants. NF-kB signaling (C): HEK-hTLR4 SEAP reporter cells were stimulated ON with EcLPS and modulated or not with lidocaine and/or dexamethasone, and relative SEAP activity was measured in culture supernatants. Lidocaine and dexamethasone additively modulate poly I:C TLR3 signaling, but do not affect IFNAR signaling (DeE). B16 type I IFNs SEAP reporter cells were stimulated ON with poly I:C (D) or with supernatant from the same cell line previously stimulated with poly I:C (E) and modulated or not with lidocaine and/or dexamethasone. SEAP activity was measured in culture supernatants. * (p < 0.05), ** (p < 0.01), *** (p < 0.001), ****(p < 0.0001), a result significantly different from the stimulated unmodulated condition. # (p < 0.05), ## (p < 0.01), a result significantly different from its counterpart stimulated and modulated with only lidocaine at the same concentration. Data are represented as mean ± SEM of three replicates. Graphs are representative of at least two independent assays.
Article Snippet: B16 interferon gamma (IFNg) reporter cell line (InvivoGen®).
Techniques: Protein-Protein interactions, Activity Assay, Concentration Assay